Using intermittent theta burst stimulation to treat fibromyalgia
Official title: The Effect of Intermittent Theta Burst Stimulation to the Primary Motor Cortex on Pain Intensity, Pain Catastrophizing, Quality of Life and Mood in Fibromyalgia Patients
Run by Izmir Katip Celebi University · NCT06746922 · Data updated 2026-11-12
This study is testing if a new brain stimulation technique can help people with fibromyalgia feel less pain and manage their symptoms better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Izmir Katip Celebi University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Izmir, Karabaglar) |
| Status | Recruiting |
| Started | March 13, 2025 |
| Main results expected | February 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | March 18, 2025 |
| Trial ID | NCT06746922 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-65 diagnosed with fibromyalgia syndrome and experiencing moderate to severe pain.
✕Probably not a fit
Patients with contraindications for transcranial magnetic stimulation, such as those with metallic implants or serious neurological conditions, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of intermittent theta burst stimulation (iTBS), a form of repetitive transcranial magnetic stimulation (rTMS), on patients diagnosed with fibromyalgia syndrome. It aims to include at least 30 participants aged 18-65 who have been experiencing chronic pain and other symptoms associated with fibromyalgia. The study will compare the effects of active iTBS treatment against a sham treatment to evaluate its efficacy in pain relief and symptom management. The research is being conducted at İzmir Katip Çelebi University Atatürk Training and Research Hospital, focusing on a population that has stable fibromyalgia treatment for the past three months.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improve the quality of life for patients suffering from fibromyalgia.
How similar studies have gone: While there is increasing research on rTMS for fibromyalgia, this specific approach using iTBS is relatively novel and has not been widely tested in the literature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 18-65 * Being diagnosed with fibromyalgia syndrome (according to 2016 criteria) * Average pain intensity of NRS ≥ 4/10 * Fibromyalgia treatment was stable for the last 3 months and no treatment change was planned during the study Exclusion Criteria: * Having a clinical condition that would constitute a contraindication for TMS (metallic implant, cardiac pacing, pregnancy, epilepsy, head trauma, history of cranial operation...) * Presence of malignancy * Systemic rheumatologic diseases * Major orthopedic problems limiting activities of daily living (gait disturbance or fracture sequelae limiting joint mobility, prostheses, nerve-tendon injuries) * Serious neurological diseases (increased intracranial pressure, presence of space-occupying lesions in the brain, history of epilepsy, presence of cerebral aneurysm, Parkinson's disease, Huntington's chorea, multiple sclerosis, history of previous head trauma causing loss of consciousness) * Alcohol or drug addiction * History of major depression/personality disorder or psychosis * Having received TMS treatment before * Taking benzodiazepine, gabapentin/pregabalin or anticonvulsant medications that have the potential to interfere with intermittent theta burst stimulation treatment or have taken them within the last 4 weeks * Pregnant or planning pregnancy or breastfeeding
Where it's running
-
Izmir Katip Çelebi University Atatürk Training and Research Hospital
Izmir, Karabaglar, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Ayhan ASKIN, Professor
- Email: ayhan.askin@ikc.edu.tr
- Phone: 902322444444
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory Function in Fibromyalgia: A Look at Breath and Muscle Health in Women
This study compares respiratory function, muscle strength, and quality of life between women with fibromyalgia and healthy women to see if fibromyalgia affects breathing and muscle performance.
-
Interoceptive Sensitivity and Central Sensitization in Fibromyalgia
This study tests how people with fibromyalgia perceive internal bodily signals and whether that relates to their symptom burden.
-
Psychologically Informed Physical Therapy (PIPT) for Fibromyalgia delivered online
A small online program tests if a psychologically informed physical therapy approach is feasible, acceptable, and safe for adults with fibromyalgia to help manage symptoms and improve daily functioning.
-
Melatonin and vitamin drip for pain relief in fibromyalgia
This trial tests whether weekly intravenous vitamins plus melatonin can reduce pain and improve quality of life for adults with fibromyalgia compared with a placebo.
-
Remote electrical neuromodulation to test pain inhibition in migraine and fibromyalgia
We’re testing if the Nerivio wearable can boost the body’s natural pain-inhibition system (CPM) and reduce pain more than a sham device in adults with migraine or fibromyalgia.
-
Thickness of the thoracolumbar fascia in women with fibromyalgia
This study tests whether the thoracolumbar fascia is thicker in women with fibromyalgia compared to healthy women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.